Give Hope Blog
Survivor Month: A second chance, thanks to CAR T trial
June 27, 2019 | Dory Benford
Tyler Routh is one of 13 leukemia patients who had a remarkable recovery after participating in Dr. Samer Khaled’s CAR T trial.
City of Hope investigates a novel therapeutic approach in AML
April 26, 2019 | City of Hope
City of Hope opens recruitment for a phase I/II dose-finding study of novel agent 8-chloro-adenosine in patients with relapsed/refractory acute myeloid leukemia.
First FDA-approved CAR T Therapy for Some Types of ALL to Be Offered at City of Hope
April 13, 2018 | Letisia Marquez
City of Hope recently announced that it is a certified treatment center to administer tisagenlecleucel CAR T cell therapy – the first CAR T cell therapy approved by the U.S. Food and Drug Administration – to patients.
ASH 2016: Groundbreaking new trials show promise for lymphoma and multiple myeloma patients
December 7, 2016 | City of Hope
Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.